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Abstract
Recent technological and methodological developments have enabled the use of array-based DNA 
methylation data to call copy number variants (CNVs). ChAMP, Conumee and cnAnalysis450k 
are popular methods currently used to call CNVs using methylation data. However, so far, no 
studies have analyzed the reliability of these methods using real samples. Data from a cohort of 
individuals with genotype and DNA methylation data generated using the HumanMethylation450 
and MethylationEPIC BeadChips was used to assess the consistency between the CNV calls 
generated by methylation and genotype data. We also took advantage of repeated measures of 
methylation data collected from the same individuals to compare the reliability of CNVs called by 
ChAMP, Conumee, and cnAnalysis450k for both the methylation arrays. ChAMP identified more 
CNVs than Conumee and cnAnalysis450k for both the arrays and, as a consequence, had a higher 
overlap (~62%) with the calls from the genotype data. However, all methods had relatively low 
reliability. For the MethylationEPIC array, Conumee had the highest reliability (57.6%), whereas 
for the HumanMethylation450 array, cnAnalysis450k had the highest reliability (43.0%). Overall, 
the MethylationEPIC array provided significant gains in reliability for CNV calling over the 
HumanMethylation450 array but not for overlap with CNVs called using genotype data.
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Introduction
The human genome has extensive copy number variation (CNV), which is defined as a 
segment of DNA larger than 50 base pairs that differs in copy number from a reference 
genome (McCarroll et al., 2006; Pinto, Marshall, Feuk, & Scherer, 2007; Redon et al., 2006; 
Zarrei, MacDonald, Merico, & Scherer, 2015). Such variants range in size from 50 base 
pairs to >500 kilobases (kb), and most healthy people carry numerous CNVs (Feuk, Carson, 
& Scherer, 2006; Pinto et al., 2007; Zarrei et al., 2015). Despite the presence of CNVs in 
healthy individuals, they have also been associated with changes in gene expression, 
alterations in gene dosage, and a wide range of other outcomes, including the onset of 
disease (Redon et al., 2006; Zarrei et al., 2015). For example, pathogenic CNVs have been 
associated with congenital malformations (Di Gregorio et al., 2015), schizophrenia (Cnv, 
Schizophrenia Working Groups of the Psychiatric Genomics, & Psychosis Endophenotypes 
International, 2017), and environmental exposures (Du et al., 2017; Martinez et al., 2010), 
among others (Cuccaro, De Marco, Cittadella, & Cavallaro, 2017; Poniah et al., 2017; 
Quintela et al., 2017). Thus, the ability to identify and characterize CNVs as pathogenic or 
benign may provide novel insight into a variety of adverse health outcomes.
The first CNVs were identified through low-resolution karyotypes, which gradually 
improved with the advent of chromosome banding and were further refined by fluorescence 
in situ hybridization (FISH). These techniques could identify large CNVs, but microarray 
based technology was required to further improve resolution of CNVs that could be detected 
(Feuk et al., 2006). The gold standard of CNV detection quickly became array-based 
comparative genome hybridization (array-CGH). Array-CGH uses fluorescently tagged 
reference and test samples to detect regions with copy number gains or losses (Lockwood, 
Chari, Chi, & Lam, 2006). As the field has advanced, several other methods of CNV 
detection have emerged, including using signals from genotyping and DNA methylation 
arrays and whole genome sequencing.
CNV calling algorithms for genotyping generally rely on two measures derived from probe 
intensities, log R Ratio (LRR) and allele frequency (BAF), to call CNVs. The most 
commonly used programs for CNV-calling using genotype data are Birdsuite (Malhotra et 
al., 2011), iPattern (International Schizophrenia, 2008) and PennCNV (Wang et al., 2007). 
Birdsuite is mainly used for Affymetrix assays. It assigns copy numbers based on the 
summarized intensity for common pre-identified copy number polymorphisms. A Hidden 
Markov Model (HMM) based algorithm (Colella et al., 2007) is used to assign rare CNVs 
based on the probe-specific mean and variance estimated for each SNP locus, which is 
expected to have only 2 copies. iPattern uses a pattern recognition approach to analyze the 
probe intensities of a group of samples and then uses a sliding window approach to identify 
consecutive outliers. For the defined region, samples with probe intensities that are 
significantly lower or higher than the average probe intensity of all the samples are then 
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identified as gains or losses. PennCNV also employs a HMM to detect CNVs from both 
Illumina and Affymetrix arrays. The algorithm uses not only the total signal intensity and 
allele intensity ratio like other algorithms but also incorporates distance between 
neighboring SNPs and the allele frequency of SNPs to call CNVs. To account for the relative 
strengths of the various programs, it is common to require CNVs to be called by more than 
one program and hence, pipelines for calling CNVs using genotype data involve CNV 
calling using multiple programs.
There are currently three commonly used packages to call CNVs from DNA methylation 
data: ChAMP (Feber et al., 2014), Conumee (Hovestadt & Zapatka), and cnAnalysis450k 
(Knoll, Debus, & Abdollahi, 2017). All three methods operate on the premise that the total 
methylation signal (Unmethylated Signal + Methylated Signal) is directly reflective of the 
copy number state. ChAMP has the first implementation that works on this premise and calls 
CNVs by normalizing probes based on GC content followed by circular binary segmentation 
to define regions with variations in copy number. Conumee identifies CNVs by normalizing 
experimental samples to reference samples using multiple linear regression, and then taking 
the log2-ratio of probe intensities of experimental and reference samples, followed by 
combining probes into bins and then dividing the genome into segments with the same copy 
numbers (Hovestadt & Zapatka). Finally, cnAnalysis450k identifies segments by screening 
for changes in variance of intensity between the samples and reference samples.
Genotyping arrays cannot detect translocations and inversions, while conventional DNA 
methylation arrays are biased towards detecting CNVs within genes compared to intergenic 
regions (Feber et al., 2014; Feuk et al., 2006). However, there are several advantages to 
using DNA methylation arrays exclusively to call CNVs. Feber and colleagues describe 
several of these advantages including reduction in cost and sample consumed compared to 
running both genotyping and DNA methylation arrays, as well as advantages in detecting 
and characterizing tumor heterogeneity in cancer research (Feber et al., 2014). A challenge 
of using DNA methylation arrays to call CNVs is variation in the density of methylation 
probes across different genomic regions. However, great strides have been made towards 
more completely evaluating methylation across the genome. The HumanMethylation27 
BeadChip did not have sufficient probe density to call CNVs, but the HumanMethylation450 
BeadChip (450k array) saw the development of CNV calling algorithms for DNA 
methylation datasets. The MethylationEPIC BeadChip (EPIC array) arrays provide further 
density and much more comprehensive coverage of the genome, potentially resulting in 
improved reliability for CNV calling.
Despite the wide implementation of these methods, there has been little research on the 
reliability of the algorithms in identifying the CNVs. Analyzing the reliability of these 
methods has become increasingly crucial with the advent of the EPIC array, which queries 
many more CpG sites than the 450k array. Hence, this paper evaluates the reliability of the 
popular CNV calling algorithms by: i) testing the ability of the algorithm to call the same 
CNVs as the ones called using genotype data within the same individuals and ii) testing the 
ability of the algorithm to call the same CNVs at multiple time points of a longitudinal 
dataset and comparing repeated measures within individuals.
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Methods
Study cohorts
Grady Trauma Project (GTP) cohort—Samples from the Grady Trauma Project (GTP) 
were used to assess the ability of each algorithm to call CNVs from a GWAS pipeline. The 
participants are all adult, primarily African American, female, and have been previously 
described (Binder et al., 2008; Gillespie et al., 2009; Ressler et al., 2011). Samples were 
collected from the general medical clinics of Grady Memorial Hospital, Atlanta, GA, USA. 
Participants who were waiting for appointments in the primary care and obstetrics and 
gynecology clinics were approached by a member of the research team to conduct screening 
interviews and collect saliva samples. After completion of initial interviews, study 
participants were invited to participate in a secondary phase of the study in which blood 
samples were collected. DNA was extracted from saliva by Oragene collection vials (DNA 
Genotek, Ottawa, ON, Canada) using the DNAdvance kit (Beckman Coulter Genomics, 
Danvers, MA, USA) for genotyping. DNA was extracted from blood samples using the 
E.Z.N.A. Mag-Bind Blood DNA Kit (Omerga Bio-Tek, Nocross, GA, USA) or ArchivePure 
DNA Blood Kit (5 Prime, Gaithersburg, MD, USA) and assessed for DNA methylation. This 
study was approved by the Emory Institutional Review Board.
Emory University African American Microbiome in Pregnancy (AAMP) cohort
—Samples from AAMP were used to assess reliability for each algorithm to call CNVs in 
multiple samples from the same individual. AAMP is a longitudinal cohort comprised of 142 
pregnant African American women, the recruitment and demographics of which have been 
previously described (Corwin et al., 2017; Knight et al., 2017). Briefly, women were 
recruited from prenatal care clinics affiliated with two Atlanta metro area hospitals, Emory 
University Midtown Hospital and Grady Memorial Hospital. Study participants contributed 
two blood samples each over the course of their pregnancy. The first sample was collected 
between 6–15 weeks gestation and the second sample was collected at 22–33 weeks 
gestation. Peripheral blood mononuclear cells (PBMCs) were isolated from whole blood 
using a Ficoll density gradient and were stored in AllProtect Buffer (Qiagen) at −80 °C until 
a simultaneous DNA and RNA extraction using the AllPrep RNA/DNA Mini Kit (Qiagen) 
was performed according to manufacturer’s instructions. DNA quantification and quality 
was assessed using the Quant-it Pico Green kit (Invitrogen).This study was approved by the 
Emory Institutional Review Board.
Statistical analyses
All analyses were performed in R version 3.4.1.
CNV calling from genotype data—Genome-wide SNP genotyping was done using the 
Illumina Omni1-Quad BeadChip, which interrogates 1,011,219 individual SNPs. For each 
GTP subject, GenomeStudio exported files were used to call CNVs using the iPattern 
(International Schizophrenia, 2008) and PennCNV (Wang et al., 2007) algorithms following 
the methodology laid out by Marshall et al (Marshall et al., 2017). The intersection of 
PennCNV and iPattern calls was taken, such that calls were only retained if they were made 
by both methods and the predicted copy number state matched. Quality control metrics, 
Kilaru et al. Page 4
Genet Epidemiol. Author manuscript; available in PMC 2021 March 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
including Log R Ratio SD, B Allele Frequency SD, and GC waviness were estimated from 
PennCNV. Samples were checked to ensure that the total region spanned by CNV or any of 
the other 3 QC measures was lesser than the overall sample median + 3 standard deviations. 
Large CNVs appearing to be split were annealed. Samples were checked for possible 
aneuploidy based on >10% of any chromosome being spanned by CNVs. CNVs spanning 
centromeres or overlapping telomeres (defined as 100kb from the chromosome end) were 
excluded, as were CNVs with >50% overlap with known segmental duplication, 
immunglobulin, or T-cell receptor loci. CNVs spanning <20kb, or containing <10 probes 
were excluded from further analyses.
DNA methylation data—DNA methylation was assessed on either the Illumina 
HumanMethylation450 BeadChip or the Illumina MethylationEPIC BeadChip, which assess 
>450,000 and >850,000 CpG sites across the genome, respectively. Briefly, 1 μg of DNA 
was processed and hybridized to the BeadChip, according to manufacturer’s instructions 
(Illumina, San Diego, CA). The raw data was processed using default parameters 
recommended by the developers so as to allow for a realistic comparison between the 
methods. All the samples included in the analyses were filtered through the same QC 
protocol to ensure that they have a reliable signal for more than 95% of the CpG sites. DNA 
methylation data from the GTP cohort can be accessed through NCBI’s Gene Expression 
Omnibus: GSE72680 (450k) and GSE132203 (EPIC). DNA methylation data from the 
AAMP cohort can be accessed through NCBI’s Gene Expression Omnibus: GSE107459 
(450k) and GSE122408 (EPIC).
Calling CNVs using methylation data—CNVs were called using the R packages 
ChAMP and Conumee, with default parameters. cnAnalysis450k allows the user to choose 
from a range of normalization methods and several workflow options (Workflow A: Raw 
normalized data followed by Dasen normalization, Workflow B: Raw normalized data 
followed by Dasen normalization and z-transformation, Workflow C: Raw normalized data 
is used to identify segments with the Conumee package)(Knoll et al., 2017). We followed 
the recommendation of the package’s authors in the original manuscript and implemented 
“Workflow B”, which uses a z-transformation following Illumina normalization(Knoll et al., 
2017). All the methods work on the assumption that the total intensity of the reference 
samples represents the baseline state of the genome and the observed differences between 
the total intensity of the reference samples and the individual samples represent a copy 
number variant. Since it is important to ensure that CNV detection is not affected by cell 
type differences or any other technical artifacts, samples from the same experiment were 
chosen as the reference samples. To ensure a realistic comparison, the same samples were 
used as the reference samples to call CNVs for all three methods. CNV calls were performed 
separately for the two cohorts and the two arrays. CNV location and size were annotated 
based on the NCBI build 37. DNA methylation data was used to estimate proportions of cell 
types for each sample using the method described by Houseman et al(Houseman et al., 
2012).
Overlap evaluation between CNVs generated by methylation and genotype 
data—In the GTP dataset, 90 samples had methylation data from both the 
Kilaru et al. Page 5
Genet Epidemiol. Author manuscript; available in PMC 2021 March 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
HumanMethylation450 and Human MethylationEPIC arrays, and genotype data from the 
Illumina Omni1-Quad BeadChip. CNVs called from each platform were independently 
compared to the CNVs generated from the genotype data. For the purposes of this 
comparison, an overlap with any region of the CNVs called by the genotype data was 
considered to be an overlap as long as they are the same copy number type. The final overlap 
% was calculated for each method and array type using the formula:
# CNVs detected by both genotype data and methylation data
# CNVs detected by the genotype data
For comparison across methylation methods, CNVs are considered to be overlapping as long 
as they are identified within the same sample, have a positional overlap of greater than 50% 
and reflect the same copy number. Once the counts of overlapping CNVs between any two 
methods and all the three methods were determined, the R library VennDiagram (Chen & 
Boutros, 2011) was used to generate the Venn diagram.
Reliability evaluation—To evaluate reliability in the same person, CNVs were called for 
each participant in the AAMP study at both the baseline and the follow-up visits. For 
evaluations of reliability, we focused on CNVs >10 kb in size as smaller CNVs may be less 
reliably detected on these platforms. Only CNVs that were identified at both time points 
were considered to be reliable. Since the boundaries of a particular CNV call can vary 
between samples, CNVs were considered to be reliable if the CNVs identified at the two 
time points within an individual have an overlap of greater than 50% and are the same copy 
number variation.
Reliability was calculated and reported for each time point within each method/array and 
was calculated as follows:
Total # reliable CNVs across all individuals
Total # CNVs detected across all individuals within a time point
Reliability for each individual within each method/array was calculated as follows:
2 * # reliable CNVs detected
# CNVs detected in time point 1 + # CNVs detected in time point 2
Results
Overlap of CNV calls from genotyping data
Genotyping data was available for 90 participants in the GTP study, all of which also had 
DNA methylation data assessed on both the HumanMethylation450 BeadChip and the 
MethylationEPIC BeadChip. The GTP cohort was used to assess the overlap between the 
genotype calls and the methylation calls, and, the overlap between the methylation methods. 
The number of CNVs called (Supplementary Table 1) using the genotype data was much 
lower than the number of CNVs called using the methylation data. Within the methods used 
to call CNVs using methylation data, ChAMP called the highest number of CNVs of the 
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three methods across all subjects and within subject (Table 1) for both the 450k and EPIC 
arrays. Conumee called the fewest CNVs within the 450k array and cnAnalysis450k called 
the fewest CNVs with the EPIC array. The distribution of CNVs detected differed by 
methods and arrays is shown in Figure 1. The average size of CNVs called using the 
genotype data was much lower than the average size of CNVs called using the methylation 
data. Within the methylation methods, cnAnalysis450k detected CNVs with the largest size 
within both the 450k and EPIC arrays. The CNVs called by the three methods using 
methylation data were compared to the CNVs called using genotype data and the overlap 
percentages are reported in Table 2 for each individual array and method. ChAMP detected 
62% of the CNVs detected by the genotype data for both the 450k and EPIC arrays. The 
overlap percentages for Conumee and cnAnalysis450k were substantially lower regardless of 
the array used. Interestingly, most of the CNVs detected using methylation data are not 
detected when using genotype data irrespective of the array/ method used.
Evaluation of CNV overlap across the DNA methylation methods
A higher degree of overlap was observed between the CNVs detected by cnAnalysis450k 
and those detected by Champ for both the EPIC array and 450k array. Figure 2 represents 
this comparison for both the arrays. There were 17 CNVs (Supplementary Figure 1) that 
were detected across all three methods within the 450K array and 71 CNVs that were 
detected across all three methods within the EPIC array.
Evaluation of reliability across CNVs called by methylation methods
DNA methylation data were available for 142 women in the AAMP study, with samples at 
both study timepoints over pregnancy. Of these 142 women, methylation was assayed via the 
HumanMethylation450 BeadChip for 53 (37%) participants and via the MethylationEPIC 
BeadChip for 89 (63%) participants. This cohort was used to calculate and analyze 
reliability measures. To compare reliability of detection across methods, we computed the 
percent of baseline calls that were reliable, and the percent of follow-up calls that were 
reliable. As detailed in Table 3, all three methods detected CNVs more reliably using the 
EPIC array. Conumee, which identified CNVs with a low reliability when using the 450k 
array, identified CNVs with the highest reliability of all three methods when the EPIC array 
was used (57.6%). cnAnalysis450k had the best reliability of the three methods when 
detecting CNVs using the 450k array (43.0%). However, there was a wide range of 
reliability metrics across subjects (Table 4; Supplementary Figure 2).
Evaluation of the impact of cell composition and array position on reliability
To evaluate whether differences in cell composition across blood samples were responsible 
for the variance in reliability at the sample level, the difference in the cellular composition 
(operationalized as percent CD8+ T cells, CD4+ T cells, natural killer cells, monocytes, B 
cells) between the matched samples was regressed on the individual reliability measures 
(Supplementary Table 2). CD8+ T cell composition was associated with individual 
reliability measures for Conumee within the 450K array; there were no other significant 
associations between the differences in cell types and the individual reliability measures. 
Also, considering that the number of CNVs detected varied across samples, the number of 
CNVs called per sample was evaluated for association with cell composition, batch, and 
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position (Tables 5 and 6). The number of CNVs called per sample was highly associated 
with the chip the samples were run on within the EPIC array for all the methods and was 
associated with the chip within the 450k array for cnAnalysis450k (Supplementary Figure 
3). As the number of CNVs detected is associated with the chip the samples were run on, the 
individual-specific reliability measures were tested for association with the chip they were 
run on and array position. Supplementary Table 3 shows that individual reliability of CNV 
calls is associated with chip for ChAMP within the EPIC array (F=3.0, p=5E-03) and for 
cnAnalysis450k (F=2.2, p=0.04) and ChAMP within the 450K array (F=1.7, p=0.05).
Discussion
Genotyping data is widely used to call CNVs and we compared calls generated from this 
gold-standard to those made by three methylation-based methods (ChAMP, cnAnalysis450k 
and Conumee). ChAMP calls 62% of the CNVs called by the genotype data but the other 
methods call a substantially lower number of CNVs called by the genotype data and this 
may partially be explained by the fact that ChAMP calls substantially more CNVs than 
Conumee and cnAnalysis450k. However, almost 95% of the CNVs called using methylation 
data are not called by genotype data irrespective of the array or method used. This can be 
attributed to the fact that the number of CNVs detected from the genotype data is much 
lower than the number of CNVs detected by any of the methylation-based methods. This is 
to be expected considering that, for the genotype data, only the CNVs that were commonly 
detected across two methods were used for this comparison. The methylation methods not 
only call substantially more CNVs but also substantially larger CNVs. In some cases, the 
packages call almost whole chromosomes as CNVs in subjects that are extremely unlikely to 
be cases of aneuploidy. Given the stark differences in the CNVs called by the methylation-
based arrays compared to the ones called using the genotype arrays, we further examined the 
reliability of CNVs called using methylation-based methods.
Each of the three methods called more CNVs using the EPIC array compared to the 450K 
array, due to the increased CpG density within the EPIC array. ChAMP detected the highest 
number of CNVs regardless of the array but also had a tendency to detect very small CNVs. 
Conumee detected more CNVs than cnAnalysis450k within the EPIC array but detected 
fewer CNVs than cnAnalysis450k within the 450k array. However, none of the methods 
substantially agreed with each other, as the overlap between the CNVs detected by any two 
methods for the baseline samples did not exceed 36%. Of the three methods, 
cnAnalysis450k called CNVs that have a high degree of overlap with the ones called by 
ChAMP (36% within the 450k array and 30% within the EPIC array).
Calling CNVs using an EPIC array improved the reliability for all pipelines as the higher 
density of CpGs within the EPIC array allowed the algorithms to call the regions with a 
higher confidence than when calling within the 450k array. Across the pipelines and arrays, 
Conumee called CNVs with the highest reliability within an individual using the EPIC array. 
Conumee calls CNVs based on predefined regions unlike the other methods, which is the 
most likely reason for its high reliability. However, this pattern does not hold within the 
450k array where cnAnalysis450k calls CNVs with the highest reliability. To evaluate the 
sensitivity of the pipelines to the reference samples used, all the pipelines were rerun for the 
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EPIC array using technical replicates as the reference instead of other samples from the 
same experiment. This change does not appear to substantially affect ChAMP and Conumee 
as ChAMP’s reliability increased only slightly from 39.5% to 41.2%, and Conumee’s 
reliability decreased slightly from 57.6% to 53.2%. However, cnAnalysis450k seems to be 
sensitive to the reference samples used as the reliability decreased from 47.3% to 32.9% 
when technical replicates were used instead of the other samples.
When the reliabilities were compared at the sample level, they varied dramatically. For 
example, even though Conumee called CNVs at a reliability of 57.6% on average, the 
individual-level reliability ranged from 0% to 82.5%. Data generated by Infinium 
methylation arrays is prone to batch effects but that is unlikely to affect the reliabilities 
greatly as both the samples from within an individual were run on the same chip. 
Hypothesizing that the variance in reliability was caused by the differing cell composition 
within the samples, the sample level reliabilities were regressed on the difference between 
the cell compositions. Although within the 450k array, change in CD8+ cells was associated 
with individual-specific reliability for Conumee, the same pattern was not detected within 
the EPIC array. The variance in the reliabilities was also due, in part, to the differing number 
of CNVs detected per sample. The number of CNVs detected per sample was associated 
with the chip the sample was run on and consequently, the reliability was mildly associated 
with chip for Champ within EPIC and for ChAMP and cnAnalysis450k within 450k. The 
cell types and array position do not seem to have a consistent effect on the number of CNVs 
called per sample across the methods and arrays.
From the results, it is clear that the EPIC array detects CNVs with a substantially higher 
reliability than the 450k array regardless of the method chosen, with the best achievable 
reliability being 57.6% using Conumee with the EPIC array. Also, considering that the 
number of CNVs detected per sample is highly associated with array designation, it is 
evident that running the pipelines with default parameters does not handle the array specific 
biases in the data and so, it may be prudent to call CNVs after adjusting for the effect of the 
array designation using methods such as ComBAT (Johnson, Li, & Rabinovic, 2007). 
Considering CNVs detected using array based methylation data is not highly reproducible 
and do not overlap with the ones detected using the genotype data, CNVs detected using the 
EPIC arrays are only useful as a first pass analysis. Hence, we recommend that researchers 
validate CNVs called using array based DNA methylation data with techniques such as 
FISH or quantitative PCR before analyzing, interpreting and reporting their biological 
implications.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Histograms of the number of CNVs detected per sample for the genotype data and the 
methylation data separated by method/array. The x-axis represents the number of CNVs 
detected per sample and the y-axis represents the frequency.
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Figure 2. 
The Venn diagrams below represents the total number of CNVs detected for each method, 
the number of CNVs that overlap between the two methods, and the number of CNVs that 
overlap between all three methods for both the arrays.
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Table 1.
Average number and size of the CNVs called by genotype and methylation data for each array and method 
within the GTP cohort for the same subjects.
450k, N=90 EPIC, N= 90
Average #CNVs Size (in kb) Average #CNVs Size (in kb)
Genotype 5 103 5 103
CHAMP 88 31,540 138 20,124
Conumee 8 38,465 25 28,281
cnAnalysis450k 21 48,832 29 49,218
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Table 2.
Overlap between the CNVs called by genotype data and the methylation data for all the three methods within 
the GTP cohort.
450k Array EPIC Array
% of genotype
CNVs called by
methylation data
% of methylation
CNVs called by
genotype data
% of genotype
CNVs called by
methylation data
% of methylation
CNVs called by
genotype data
CHAMP 62.3% 4.0% 62.1% 2.5%
Conumee 7.8% 5.4% 14.3% 3.2%
cnAnalysis450k 12.7% 4.0% 14.7% 3.3%
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Table 3.
Reliability of CNVs called by method for the 450k and EPIC arrays. Data is presented at the baseline visit, 
notated as V1, and the follow-up visit, notated as V2. The values in the table represent the total number of the 
CNVs detected across all the samples for each method/time point.
450k Array, N=106 (53 pairs)
V1 & V2 V1 Reliability V1 (%) V2 Reliability V2 (%) Overall Reliability (V1+V2)/2
CHAMP 1,854 6,506 28.5% 6,560 28.3% 28.4%
Conumee 290 1,271 22.8% 1,379 21.0% 21.9%
cnAnalysis450k 1,365 3,240 42.1% 3,107 43.9% 43.0%
EPIC Array, N=178 (89 pairs)
V1 & V2 V1 Reliability V1 (%) V2 Reliability V2 (%) Overall Reliability (V1+V2)/2
CHAMP 39,550 97,321 40.6% 103,032 38.4% 39.5%
Conumee 6,780 11,412 59.4% 12,120 55.9% 57.6%
cnAnalysis450k 1,891 4,036 47.1% 3,992 47.4% 47.3%
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Table 4.
Summary statistics of the individual reliabilities for each method/array.
450k Array, N=106 (53 pairs) EPIC Array, N=178 (89 pairs)
Mean SD Range Mean SD Range
CHAMP 30.8% 13.7% 3.4%−63.6% 35.4% 19.4% 1.2%−78.2%
Conumee 19.2% 18.2% 0.0%−85.7% 51.0% 25.4% 0.0%−82.5%
cnAnalysis450k 39.8% 18.7% 0.0%−73.0% 40.9% 24.0% 0.0%−82.3%
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Table 5.
Association between the number of CNVs detected and cellular composition.
450k Array, N=106 (53 pairs) EPIC Array, N= 178 (89 pairs)
ChAMP Conumee cnAnalysis450k ChAMP Conumee
cnAnalysis
450k
t p t p t p t p t p t p
CD8 −0.1 0.96 −0.4 0.71 0.6 0.56 2.6 1E-02 1.5 0.12 1.2 0.25
CD4 0.5 0.64 −1.5 0.15 0.9 0.39 −0.9 0.34 −1.2 0.23 0.8 0.45
NK −1.4 0.15 −1 0.3 0.1 0.97 −2.4 1E-02 −0.8 0.42 −1.5 0.13
BCell −0.2 0.86 −0.1 0.93 −0.3 0.74 0.5 0.60 0.4 0.72 1.9 0.06
Mono −0.5 0.6 0.9 0.37 −1 0.31 −0.1 0.93 −0.7 0.47 −1.5 0.13
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Table 6.
Association between the number of CNVs and array designation (chip) or position on the array (row).
450k, N=106 (53 pairs) EPIC N= 178 (89 pairs)
ChAMP Conumee cnAnalysis450k ChAMP Conumee cnAnalysis450k
F p F p F p F p F p F P
Chip 1.8 0.06 1.1 0.41 3 2E-03 7.2 4.3E-16 5.8 5.6E-13 2.9 4.8E-05
Row 1.5 0.13 1.7 0.09 0.7 0.77 0.8 0.6 1 0.45 2 0.06
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